Ghana’s pharmaceutical industry has entered its ‘golden era’ – NVI CEO

The Chief Executive of the National Vaccine Institute (NVI), Dr Sodzi Sodzi-Tettey, has declared that Ghana’s pharmaceutical industry has entered its “golden era” as the government launched a new policy framework on Wednesday, October 28, 2026. The new policy aims to transform Ghana into a continental hub for medicine and vaccine manufacturing. Speaking at the launch of the Ghana Pharmaceutical Manufacturing Policy (GPMP) at the Ghana EXIM Bank premises, Dr Sodzi-Tettey said the policy would address critical questions that have long hindered financing for local manufacturers. He said Ghana’s decade-long ambition to lead Africa in pharmaceutical production was now being backed by concrete action, rather than words alone.

“We are witnessing the golden era of the pharmaceutical industry in Ghana,” Dr Sodzi-Tettey told an audience that included the Minister of Trade, Agribusiness and Industry, Elizabeth Ofosu-Adjare, and the Minister of Health, Kwabena Mintah Akandoh. “In a few years to come, this will be self-evident. ” Dr Sodzi-Tettey said the GPMP was a direct response to the financing challenges facing the sector. He noted that the NVI was tasked with mobilising resources for two private manufacturers and partners, Atlantic Lifesciences and DEK Vaccines Ltd, which require at least $100 million to build and equip their plants. “When we approach Development Finance Institutions, a few questions are thrown back at us: How supportive is government of these initiatives? Will your government buy the vaccines and the medicines you are planning to manufacture? Does your government have any policy on local manufacturing? ” he said. “I can confidently respond and say… Ghana has a Pharmaceutical Manufacturing Policy which articulates in clear, concrete terms the support that…